---
figid: PMC5795989__ijms-19-00039-g001
figtitle: BMP-triggered signalling pathway and major regulators
organisms:
- Mus musculus
- Rattus norvegicus
- Hepatitis B virus
- Adeno-associated virus
- Homo sapiens
- Danio rerio
- NA
pmcid: PMC5795989
filename: ijms-19-00039-g001.jpg
figlink: /pmc/articles/PMC5795989/figure/ijms-19-00039-f001/
number: F1
caption: 'BMP-triggered signalling pathway and major regulators. BMP ligand binds
  to its membrane serine/threonine kinase receptors type I and type II. Once the heterotetrameric
  complex is formed, constitutively active type II receptor transphosphorylates the
  type I receptor to initiate intracellular signalling. In the canonical pathway,
  R-Smads are phosphorylated by type I receptor and subsequently bind to Co-Smad,
  Smad4. The resulting complex translocates to the nucleus where it recruits specific
  co-activators, co-repressors and transcription factors to regulate the expression
  of target genes and microRNA that in turn will target specific mRNAs. This pathway
  is strictly controlled by different means. Extracellular antagonists/inhibitors
  (Dan, Twisted, Noggin, etc.) and decoy receptors (Bambi) and co-receptors (endoglin,
  beta-glycan, RGM/dragon, RTKs…) in the plasma membrane regulate binding of BMP ligand
  to its membrane serine/threonine kinase receptors. Additional regulators include
  CK2, I-Smads, phosphatases (PP1 and PP2A) and ubiquitin ligases among others. BMP
  also activate several non-Smad pathways, including Rho small GTPases, LIMK, PI3K/AKT,
  PKC and ERK, JNK and p38 MAPKs which modulate BMP cellular responses. Bambi: BMP
  and activin membrane bound inhibitor; CK2: Casein kinase II; ILK: Integrin-linked
  kinase; LIM kinase: Lin-11/Isl-1/Mec-3 gene products kinase; MAPK: mitogen-activated
  protein kinase; PI3K phosphatidylinositol 3-kinase; PP1: Protein phosphatase 1;
  PP2A: Protein phosphatase 2A; RGM: repulsive guidance molecules; RTK: receptor tyrosine
  kinases; TAK: TGF-β-activated kinase; TAB: TAK binding proteins.'
papertitle: BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration.
reftext: Blanca Herrera, et al. Int J Mol Sci. 2018 Jan;19(1):39.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9770279
figid_alias: PMC5795989__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
redirect_from: /figures/PMC5795989__F1
ndex: 8e93b3f0-deb6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5795989__ijms-19-00039-g001.html
  '@type': Dataset
  description: 'BMP-triggered signalling pathway and major regulators. BMP ligand
    binds to its membrane serine/threonine kinase receptors type I and type II. Once
    the heterotetrameric complex is formed, constitutively active type II receptor
    transphosphorylates the type I receptor to initiate intracellular signalling.
    In the canonical pathway, R-Smads are phosphorylated by type I receptor and subsequently
    bind to Co-Smad, Smad4. The resulting complex translocates to the nucleus where
    it recruits specific co-activators, co-repressors and transcription factors to
    regulate the expression of target genes and microRNA that in turn will target
    specific mRNAs. This pathway is strictly controlled by different means. Extracellular
    antagonists/inhibitors (Dan, Twisted, Noggin, etc.) and decoy receptors (Bambi)
    and co-receptors (endoglin, beta-glycan, RGM/dragon, RTKs…) in the plasma membrane
    regulate binding of BMP ligand to its membrane serine/threonine kinase receptors.
    Additional regulators include CK2, I-Smads, phosphatases (PP1 and PP2A) and ubiquitin
    ligases among others. BMP also activate several non-Smad pathways, including Rho
    small GTPases, LIMK, PI3K/AKT, PKC and ERK, JNK and p38 MAPKs which modulate BMP
    cellular responses. Bambi: BMP and activin membrane bound inhibitor; CK2: Casein
    kinase II; ILK: Integrin-linked kinase; LIM kinase: Lin-11/Isl-1/Mec-3 gene products
    kinase; MAPK: mitogen-activated protein kinase; PI3K phosphatidylinositol 3-kinase;
    PP1: Protein phosphatase 1; PP2A: Protein phosphatase 2A; RGM: repulsive guidance
    molecules; RTK: receptor tyrosine kinases; TAK: TGF-β-activated kinase; TAB: TAK
    binding proteins.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nbl1
  - Parn
  - Rgmb
  - Bambi
  - Limk1
  - Csnk2a1
  - Csnk2a2
  - Ppp1cc
  - Npy4r
  - Smad7
  - Smad6
  - Smurf1
  - Smurf2
  - pk
  - Ppp2ca
  - Ppp2r1a
  - Nedd4l
  - Rho
  - Rhod
  - Ea2
  - Smad9
  - Smad5
  - Smad1
  - Rnf111
  - Ilk
  - Smad4
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Mapk8
  - Ephb2
  - Mapk1
  - Akt1
  - Smad2
  - pc
  - NBL1
  - PARN
  - MICOS10-NBL1
  - GREM1
  - RGMA
  - RGMB
  - TGFBR3
  - BMP1
  - BMP2
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - BAMBI
  - LIMK1
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - PPA1
  - NPY4R
  - NPY4R2
  - SMAD7
  - SMAD6
  - SMURF1
  - SMURF2
  - PTPA
  - NEDD4L
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - SMAD9
  - SMAD5
  - SMAD1
  - GARS1
  - ILK
  - SMAD4
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - SMAD2
  - SMAD3
  - TF
  - TAB1
  - TAB2
  - TAB3
  - PC
  - Tgfbr3
  - Csnk2b
  - Prkcg
  - Ephb1
  - Tf
  - Pc
  - nbl1
  - bambia
  - parapinopsina
  - smad7
  - smad6a
  - smurf1
  - smurf2
  - rho
  - rnd2
  - smad5
  - smad1
  - ilk
  - smad4a
  - smad4b
  - mapk14a
  - mapk8b
  - kita
  - ngfra
  - smad2
  - Endoglin
---
